Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Roberts John A, Chairman & CEO. Insider active across 2 companies, notably Vyant Bio, Inc.. Cumulatively, 3 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €51k. History available since 24 May 2021. The latest transaction was filed on 24 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
John A. Roberts is the Chief Executive Officer of Vyant Bio, Inc. He leads the company's operations, focusing on business strategy and growth. His expertise in the biopharmaceutical sector is crucial in guiding Vyant in its development initiatives.